A Prospective Incident Study of Arrhythmias in Hypertrophic Cardiomyopathy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

260 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-11-05

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this research study is to understand more about various heart rhythms (electrical problems) in persons with hypertrophic cardiomyopathy with and without sleep apnea.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Hypertrophic Cardiomyopathy Pilot Study

NCT02806479

Hypertrophic Cardiomyopathy Coronary Artery Disease

COMPLETED

Sleep Apnea and Hypertrophic Cardiomyopathy (HCM)

NCT03327623

Hypertrophic Cardiomyopathy

COMPLETED

Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot and Other Congenital Heart Diseases

NCT05122962

Tetralogy of Fallot Congenital Heart Disease

RECRUITING

Risk of Pacing-induced Cardiomyopathy

NCT04269733

Pacemaker DDD Atrioventricular Block Pacing-Induced Cardiomyopathy

COMPLETED

A Comparison of Two Treatments: Pacemaker and Percutaneous Transluminal Septal Ablation for Hypertrophic Cardiomyopathy

NCT00001894

Hypertrophic Cardiomyopathy

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Adult patients with hypertrophic cardiomyopathy and without known atrial fibrillation or pacemaker/implantable cardiac defibrillation will undergo implantable loop recorder implantation. No direct interventions will be performed. Prospective observation of atrial and ventricular arrhythmia incidence and burden will be assessed, with additional analyses performed based on the presence or absence of obstructive sleep apnea.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertrophic Cardiomyopathy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Currently or previously enrolled in 17-003514 and 16-009474
* Adults age \>18 years-old with a diagnosis of hypertrophic cardiomyopathy
* Both sexes
* Able to consent

Exclusion Criteria

* Vulnerable study population
* Known atrial fibrillation or flutter (with the exception of post-operative atrial fibrillation)
* Pacemaker/ICD implantation
* Pregnancy

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No